Everolimus Norameda

Medicinal product

(Invented) name

Everolimus Norameda

Active substance (s)

Everolimuzas

Strength

2,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

Yes

ATC code (s)

L01EG02, everolimus

Marketing authorisation holder

UAB Norameda, Lietuva

Date of authorisation

2019-07-02

Date of renewal

2023-01-20

Documents

4415-4417_Everolimus Norameda_perr2023-01-20.docx

4415-4417_pakuotes lapelis_2023-01-20.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/3980/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Everolimuzas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102030	88132	1088132	lizdinė plokštelė	N30		Receptinis	LT/1/19/4415/001	Netiekiama	-	-	No	-	-	Download
102031	88133	1088133	lizdinė plokštelė	N90		Receptinis	LT/1/19/4415/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-01-20	Perregistruotas
2019-07-02	Registruotas